Abstract
Xenin-25 is a K-cell derived gut peptide with insulin-releasing activity which is rapidly degraded following release into the circulation. We hypothesized that substitution of all naturally-occurring Lys and Arg residues with Gln would lead to prolonged enzyme resistance and enhanced biological efficacy. Peptide stability was assessed using murine plasma, in vitro insulin-releasing actions evaluated in BRIN-BD11 cells and acute glucose-lowering and insulin-releasing actions examined in high fat fed mice. For sub-chronic studies, a range of metabolic parameters and pancreatic histology were assessed in high fat fed mice which had received saline vehicle or xenin-25(gln) twice-daily for 21 days. In contrast to native xenin-25, xenin-25(gln) was resistant to plasma-mediated degradation and significantly stimulated insulin secretion in BRIN-BD11 cells. Acute administration of xenin-25(gln) in high fat fed mice significantly reduced blood glucose and increased plasma insulin concentrations. Twice-daily administration of xenin-25(gln) in high fat fed mice did not affect food intake, body weight or circulating insulin concentrations but significantly decreased blood glucose from day 9 onwards. Furthermore, glucose tolerance, glucose-m...Continue Reading
References
May 1, 1981·Diabetologia·P R Flatt, C J Bailey
Oct 1, 1981·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·P R Flatt, C J Bailey
Jan 1, 1995·Peptides·G HamscherG E Feurle
Jan 1, 1993·The Journal of Clinical Investigation·M A NauckW Creutzfeldt
Jul 23, 2003·Regulatory Peptides·Ramona A SilvestreJosé Marco
Mar 23, 2004·Molecular & Cellular Proteomics : MCP·Jesper V OlsenMatthias Mann
Feb 3, 2007·Behavioural Brain Research·Mark A ClineJ Orion Rogers
Jun 15, 2007·Diabetologia·V A GaultP R Flatt
Nov 6, 2008·Diabetes·Arnold LeckstromTooru M Mizuno
Nov 28, 2008·Diabetologia·P V HøjbergS Madsbad
Feb 14, 2009·Obesity·Jennifer H CookeKevin G Murphy
Jul 16, 2010·The Journal of Endocrinology·Ashley I TaylorVictor A Gault
May 6, 2011·Diabetes Care·Jens J HolstSten Madsbad
Sep 20, 2011·Chemical Physics Letters·Dipankar Roy, J J Dannenberg
May 9, 2012·Biochemical Pharmacology·Christine M A MartinNigel Irwin
Feb 13, 2014·The Journal of Endocrinology·Christine M A MartinNigel Irwin
Citations
Apr 1, 2016·PloS One·Christine M MartinNigel Irwin
Jul 22, 2017·Diabetes, Obesity & Metabolism·Vadivel ParthsarathyFinbarr P M O'Harte
Apr 11, 2018·Diabetes/metabolism Research and Reviews·Sarah L CraigNigel Irwin
Dec 1, 2018·Diabetes/metabolism Research and Reviews·Annie HasibNigel Irwin
Apr 24, 2019·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Yusuf Adnan GucluMurat Aksit
Jul 15, 2020·Diabetes/metabolism Research and Reviews·Neil TandayNigel Irwin
Aug 20, 2017·Biological Chemistry·Dawood KhanNigel Irwin
Aug 10, 2020·Biological Chemistry·Andrew EnglishNigel Irwin
Jul 29, 2019·Molecular and Cellular Endocrinology·S L CraigN Irwin
Nov 23, 2019·Biochemical Pharmacology·S L CraigN Irwin
Jun 11, 2021·Domestic Animal Endocrinology·Takenori OnagaYumiko Yasui
Aug 10, 2021·Bioscience Reports·Rachele A PerryNigel Irwin